MetaADEDB 2.0 @ LMMD
Tolcapone
(MIQPIUSUKVNLNT-UHFFFAOYSA-N)
Structure
SMILES
Cc1ccc(cc1)C(=O)c1cc(O)c(c(c1)[N+](=O)[O-])O
Type(s)
Approved; Withdrawn
ATC code(s)
N04BX01
Molecular Formula:
C14H11NO5
Molecular Weight:
273.241
Log P:
3.0686
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
103.35
CAS Number(s):
134308-13-7
Synonym(s)
1.
Tolcapone
2.
3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone
3.
Ro 40-7592
4.
Ro-40-7592
5.
SOM0226
6.
Tasmar
7.
3,4 Dihydroxy 5' methyl 5 nitrobenzophenone
8.
Ro 40 7592
9.
Ro 407592
10.
Ro407592
External Link(s)
MeSHD000077867
PubChem Compound4659569
BindingDB50108877
ChEBI63630
CHEMBLCHEMBL1324
DrugBankDB00323
DrugCentral2697
IUPHAR/BPS Guide to PHARMACOLOGY6646
KEGGcpd:C07949
dr:D00786
Therapeutic Target DatabaseD0Y7PG
ZINC35342789
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood alkaline phosphatase increasedFAERS: 3OFFSIDES
US FAERS
2PneumoniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3Respiratory arrestFAERS: 2US FAERS
4Abdominal PainFAERS: 1SIDER
US FAERS
5AgitationFAERS: 1SIDER
US FAERS
6Alanine Aminotransferase IncreasedFAERS: 1OFFSIDES
SIDER
US FAERS
7Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
8Back PainFAERS: 1US FAERS
9Bilirubin conjugated increasedFAERS: 1US FAERS
10Blood urine presentFAERS: 1US FAERS
11Cerebrovascular accidentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
12CholelithiasisFAERS: 1SIDER
US FAERS
13ChromaturiaFAERS: 1SIDER
US FAERS
14DysarthriaFAERS: 1US FAERS
15Gamma-Glutamyltransferase IncreasedFAERS: 1OFFSIDES
US FAERS
16HepatotoxicityFAERS: 1OFFSIDES
US FAERS
17LeukocytosisFAERS: 1US FAERS
18Muscle RigidityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
19Post procedural complicationFAERS: 1US FAERS
20Pulmonary EmbolismFAERS: 1SIDER
US FAERS
21Pulmonary FibrosisFAERS: 1US FAERS
22Sudden deathFAERS: 1US FAERS
23Suicide attemptFAERS: 1US FAERS
24TremorFAERS: 1SIDER
US FAERS
25nervous system disorderFAERS: 1SIDER
US FAERS
26Abdominal Compartment SyndromeOFFSIDES
27AbscessSIDER
28Acute Coronary SyndromeSIDER
29Acute myocardial infarctionOFFSIDES
30AdenocarcinomaOFFSIDES
31AgraphiaOFFSIDES
32Akathisia, Drug-Induced11080934CTD
33AkinesiaOFFSIDES
34AlopeciaOFFSIDES
SIDER
35AmnesiaOFFSIDES
SIDER
36AmphetaminesOFFSIDES
37Angina PectorisSIDER
38AnorexiaSIDER
39AnosmiaOFFSIDES
40Antisocial Personality DisorderSIDER
41AnxietySIDER
42Aortic Valve StenosisSIDER
43Aortic valve sclerosisOFFSIDES
44ApathyOFFSIDES
SIDER
45Application site scarOFFSIDES
46ArteriosclerosisSIDER
47ArthralgiaSIDER
48ArthritisSIDER
49ArthropathySIDER
50AstheniaSIDER
51AsthmaSIDER
52Atrial FibrillationSIDER
53AutomatismOFFSIDES
54Basal ganglion degenerationOFFSIDES
55Biliary cirrhosisOFFSIDES
56BlepharospasmOFFSIDES
57Blood fibrinogenOFFSIDES
58Blood iron increasedOFFSIDES
59Blood lactate dehydrogenase increasedOFFSIDES
60BradycardiaSIDER
61BronchitisSIDER
62CarcinomaSIDER
63Cardiac ArrestSIDER
64Catalepsy7957769
8216760
CTD
65CataractSIDER
66CellulitisSIDER
67Chemical and Drug Induced Liver Injury

View details

CTD
68Chest PainSIDER
69Chest discomfortSIDER
70ChillsSIDER
71CholecystitisSIDER
72ChoreoathetosisSIDER
73Cogwheel RigidityOFFSIDES
74ColitisSIDER
75ConstipationSIDER
76Coronary Artery DiseaseSIDER
77DehydrationSIDER
78DeliriumSIDER
79Depressive disorder7768276
11224284
CTD
80DermatitisSIDER
81Diabetes MellitusSIDER
82DiplopiaSIDER
83DiscomfortSIDER
84Disturbance in sexual arousalSIDER
85DizzinessSIDER
86Dreaming excessiveSIDER
87Drug chemical incompatibilityOFFSIDES
88Drug ineffectiveOFFSIDES
89Duodenal UlcerSIDER
90DysgeusiaSIDER
91Dyskinesia, Drug-Induced11455177CTD
92DyspepsiaSIDER
93Dysthymic DisorderOFFSIDES
94DystoniaOFFSIDES
95DysuriaSIDER
96EczemaSIDER
97Edema12180806CTD
98EndophthalmitisSIDER
99EpistaxisSIDER
100Erectile dysfunctionOFFSIDES
SIDER
101Erythema MultiformeSIDER
102Euphoric moodSIDER
103Extensively Drug-Resistant Tuberculosis19578428CTD
104Eye painSIDER
105Facial NeuralgiaOFFSIDES
106FatigueOFFSIDES
SIDER
107Feeling abnormalSIDER
108Flank PainSIDER
109Flat affectSIDER
110FlatulenceSIDER
111Flight of ideasOFFSIDES
112FormicationOFFSIDES
113FractureSIDER
114FurunculosisSIDER
115GamblingOFFSIDES
116GastroenteritisSIDER
117Gastrointestinal PainSIDER
118Gastrointestinal carcinomaSIDER
119General physical health deteriorationOFFSIDES
120GlaucomaSIDER
121Hallucinations, mixedOFFSIDES
122HeadacheSIDER
123HemiplegiaSIDER
124Hepatic necrosisOFFSIDES
125HepatitisOFFSIDES
126HerniaSIDER
127HostilitySIDER
128HyperkinesiaSIDER
129HypersensitivitySIDER
130HyperventilationOFFSIDES
SIDER
131HypokinesiaOFFSIDES
SIDER
132HypophagiaOFFSIDES
133HypotensionSIDER
134Impaired gastric emptyingSIDER
135InfectionSIDER
136InfestationSIDER
137InfluenzaSIDER
138Infusion site mobility decreasedOFFSIDES
139Intention tremorOFFSIDES
140Lacrimal structural disorderSIDER
141LaryngitisSIDER
142LethargySIDER
143Liver Failure, Acute11052337CTD
144MalaiseSIDER
145Manic psychosisSIDER
146MeningitisSIDER
147Mental RetardationSIDER
148Mental deficiencySIDER
149Mental impairmentOFFSIDES
150Mitochondrial Diseases11052337CTD
151Mood swingsSIDER
152Musculoskeletal discomfortSIDER
153Musculoskeletal stiffnessSIDER
154MyalgiaSIDER
155Myocardial InfarctionSIDER
156MyoclonusSIDER
157NauseaSIDER
158Neck PainSIDER
159NephrolithiasisSIDER
160NervousnessSIDER
161NeuralgiaSIDER
162Neuroleptic Malignant SyndromeOFFSIDES
SIDER
163NeuropathySIDER
164NocturiaSIDER
165OliguriaSIDER
166Otitis MediaSIDER
167Ovarian CarcinomaSIDER
168PainSIDER
169PalpitationsSIDER
170ParanoiaSIDER
171Paranoid reactionSIDER
172ParesisSIDER
173Parkinson Disease

View details

CTD
174Performance status decreasedOFFSIDES
175Pericardial effusionSIDER
176PharyngitisSIDER
177PolyuriaSIDER
178Portal HypertensionOFFSIDES
179Prostate carcinomaSIDER
180PruritusSIDER
181RhabdomyolysisSIDER
182RhinitisSIDER
183ShockSIDER
184SinusitisSIDER
185SomnolenceSIDER
186Spinal column stenosisOFFSIDES
187StiffnessSIDER
188StomatitisSIDER
189StressOFFSIDES
190Substance Withdrawal Syndrome10866587CTD
191SweatingSIDER
192SyncopeSIDER
193TachycardiaSIDER
194TenosynovitisSIDER
195TensionSIDER
196Therapy non-responderOFFSIDES
197Therapy regimen changedOFFSIDES
198ThirstSIDER
199ThrombocytopeniaSIDER
200ThrombosisSIDER
201TinnitusSIDER
202Tuberculosis, Multidrug-Resistant19578428CTD
203Urinary IncontinenceSIDER
204Urinary RetentionSIDER
205Urinary tract infectionSIDER
206Urine output increasedSIDER
207UrticariaSIDER
208Vasodilation procedureSIDER
209VasodilationSIDER
210VertigoSIDER
211Vitiligo10573327CTD
212VomitingSIDER
213Weight decreasedSIDER
214effusionOFFSIDES
215furuncleSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.